Why One Number Isn’t Enough for Patients

• by Kerri Miller

• March 5, 2026

Cancer Screening Gaps Seen in Sexual, Gender Minority Groups

A large BRFSS analysis points to persistent screening disparities among sexual orientation and gender identity minority respondents, with particularly large gaps in some gender identity minority groups.

• by Andrea Surnit

• July 9, 2026

• 5 min

Can SGLT2 Inhibitors Affect Dementia?

A target trial emulation using Veterans Affairs electronic health records examined neuropsychiatric outcomes associated with SGLT2 inhibitor use.

• by Kathryn Wighton

• July 31, 2026

• 3 min

FDA Expands Test for Gastric and Esophageal Cancers

According to Agilent Technologies, the expanded indication covers esophageal and gastric tumor types and applies to patients being considered for nivolumab or nivolumab and hyaluronidase-nvhy.

• by Kathryn Wighton

• July 14, 2026

• 2 min